By Kathryn Hardison
Shares of China Pharma Holdings Inc. much than doubled Monday to 24 cents aft the institution announced the acquisition of a therapeutic instrumentality task for adust oculus disease.
Shares reached an intraday precocious connected Monday of 25 cents, a level past seen connected Aug. 11, according to FactSet. Shares traded 52% little for the year.
Chief Executive Li Zhilin said the device, which has a patent, is expected to code marketplace request for devices to dainty adust oculus disease, ocular fatigue and betterment aft oculus surgery, among different problems.
The institution plans to motorboat the merchandise connected the marketplace adjacent year.
Write to Kathryn Hardison astatine kathryn.hardison@wsj.com
/cdn.vox-cdn.com/uploads/chorus_asset/file/24020034/226270_iPHONE_14_PHO_akrales_0595.jpg)
English (US)